<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03332602</url>
  </required_header>
  <id_info>
    <org_study_id>Omnifortificant</org_study_id>
    <nct_id>NCT03332602</nct_id>
  </id_info>
  <brief_title>Iron Absorption From Encapsulated Iron Sulphate in Microspheres</brief_title>
  <official_title>The Effect of Encapsulation Material and Encapsulated Micronutrients on Iron Absorption in Iron Depleted Women Consuming Iron Fortified Bread.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Swiss Federal Institute of Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Swiss Federal Institute of Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Food fortification has shown to be efficacious to alleviate the burden of micronutrient
      deficiencies. Ensuring the bioavailability of iron and maintaining the sensory quality and
      stability of the fortified food and other added micronutrients remains a challenge. Soluble
      iron compounds cause minor organoleptic changes in foods but their bioavailability in man is
      rather low. Water-soluble iron compounds, such as ferrous sulphate (FeSO4), are the compounds
      in which the iron is most bioavailable; however, they often cause unfavorable sensory
      changes.

      Encapsulation of iron has excellent potential for overcoming unwanted sensory changes and
      iodine losses in salt, while maintaining acceptable bioavailability. In the present project,
      we would like to investigate the iron bioavailability from a new formulation of encapsulated
      iron sulphate based on hyaluronic acid (HA) and a polymer from the eudragit family.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 4, 2018</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in the isotopic ratio of iron in blood at week 2</measure>
    <time_frame>baseline, 2 weeks</time_frame>
    <description>The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from week 2 in the isotopic ratio of iron in blood at week 4</measure>
    <time_frame>2 weeks, 4 weeks</time_frame>
    <description>The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from week 4 in the isotopic ratio of iron in blood at week 6</measure>
    <time_frame>4 weeks, 6 weeks</time_frame>
    <description>The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Haemoglobin</measure>
    <time_frame>baseline, weeks 2, 4 and 6</time_frame>
    <description>Haemoglobin of each timepoint</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma Ferritin</measure>
    <time_frame>baseline, weeks 2, 4 and 6</time_frame>
    <description>Plasma Ferritin of each timepoint</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>inflammation marker</measure>
    <time_frame>baseline, weeks 2, 4 and 6</time_frame>
    <description>C reactive Protein of each timepoint</description>
  </secondary_outcome>
  <number_of_arms>9</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Iron-deficiency</condition>
  <arm_group>
    <arm_group_label>free FeSO4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>wheat bread fortified with free FeSO4</description>
  </arm_group>
  <arm_group>
    <arm_group_label>free FeSO4 and empty microspheres</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>wheat bread fortified with free FeSO4, and empty microspheres</description>
  </arm_group>
  <arm_group>
    <arm_group_label>free FeSO4 with eudragit polymer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>wheat bread fortified with free FeSO4, and eudragit polymer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>free FeSO4 with Hyaluronic Acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>wheat bread fortified with free FeSO4, and hyaluronic acid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>encapsulated FeSO4 3.2%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>wheat bread fortified with encapsulated FeSO4 in a microsphere with 3.2% Fe loading</description>
  </arm_group>
  <arm_group>
    <arm_group_label>encapsulated FeSO4 20%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>wheat bread fortified with encapsulated FeSO4 in a microsphere with 20% Fe loading</description>
  </arm_group>
  <arm_group>
    <arm_group_label>encapsulated FeSO4 3.2%, encap. Vitamin A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>wheat bread fortified with encapsulated FeSO4 in a microsphere with 3.2% Fe loading, and encapsulated Vitamin A as microspheres</description>
  </arm_group>
  <arm_group>
    <arm_group_label>encapsulated FeSO4 3.2%, encap. Vitamin A, free folicacid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>wheat bread fortified with encapsulated FeSO4 as microsphere with 3.2% Fe loading, encapsulated Vitamin A as microspheres and free folic acid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FeSO4 embedded in Hyaluronic Acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>wheat bread fortified with FeSO4 that is embedded in hyaluronic acid.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>free FeSO4</intervention_name>
    <description>Testmeal with free FeSO4</description>
    <arm_group_label>free FeSO4</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>free FeSO4 and empty microspheres</intervention_name>
    <description>Testmeal with free FeSO4 and empty micropsheres</description>
    <arm_group_label>free FeSO4 and empty microspheres</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>free FeSO4 and hylauronic acid</intervention_name>
    <description>Testmeal with free FeSO4 and hyaluronic acid</description>
    <arm_group_label>free FeSO4 with Hyaluronic Acid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>free FeSO4 and eudragit polymer</intervention_name>
    <description>Testmeal with free FeSO4 and eudragit polymer</description>
    <arm_group_label>free FeSO4 with eudragit polymer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>encapsulated FeSO4 3.2%</intervention_name>
    <description>Testmeal with encapsulated FeSO4 with 3.2% Fe loading</description>
    <arm_group_label>encapsulated FeSO4 3.2%</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>encapsulated FeSO4 20%</intervention_name>
    <description>Testmeal with encapsulated FeSO4 with 20% Fe loading</description>
    <arm_group_label>encapsulated FeSO4 20%</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>encapsulated FeSO4 3.2%, encapsulated Vitamin A</intervention_name>
    <description>Testmeal with encapsulated FeSO4 with 3.2% Fe loading, and encapsulated Vitamin A</description>
    <arm_group_label>encapsulated FeSO4 3.2%, encap. Vitamin A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>encapsulated FeSO4 3.2%, encapsulated Vitamin A, free Folic Acid</intervention_name>
    <description>Testmeal with encapsulated FeSO4 with 3.2% Fe loading, and encapsulated Vitamin A, with free folic acid.</description>
    <arm_group_label>encapsulated FeSO4 3.2%, encap. Vitamin A, free folicacid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>FeSO4 embedded in Hyaluronic acid</intervention_name>
    <description>Testmeal with FeSO4 embedded in Hyaluronic acid</description>
    <arm_group_label>FeSO4 embedded in Hyaluronic Acid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female, 18 to 40 years old

          -  Marginal iron status (PF &lt;25 ng/ml)

          -  Body weight &lt; 65 kg

          -  Normal body Mass Index (18.5 - 25 kg/m2)

          -  Signed informed consent

        Exclusion Criteria:

          -  Pregnancy (assessed by a pregnancy test) / intention to become pregnant

          -  Lactating up to 6 weeks before study initiation

          -  Moderate or severe anaemia (Hb &lt; 9.0 g/dL)

          -  Elevated C reactive Protein (CRP) (&gt; 5.0 mg/L)

          -  Any metabolic, gastrointestinal kidney or chronic disease such as diabetes, hepatitis,
             hypertension, cancer or cardiovascular diseases (according to the participants own
             statement)

          -  Continuous/long-term use of medication during the whole study (except for
             contraceptives)

          -  Consumption of mineral and vitamin supplements within 2 weeks prior to 1st meal
             administration

          -  Blood transfusion, blood donation or significant blood loss (accident, surgery) over
             the past 4 months

          -  Earlier participation in a study using Fe stable isotopes or participation in any
             clinical study within the last 30 days

          -  Participant who cannot be expected to comply with study protocol (e.g. not available
             on certain study appointments or difficulties with blood sampling)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Human Nutrition Laboratory, ETH Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8092</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 18, 2017</study_first_submitted>
  <study_first_submitted_qc>November 1, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2017</study_first_posted>
  <last_update_submitted>April 20, 2018</last_update_submitted>
  <last_update_submitted_qc>April 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Iron deficiency</keyword>
  <keyword>Iron fortification</keyword>
  <keyword>Iron encapsulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia, Iron-Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Vitamin A</mesh_term>
    <mesh_term>Iron</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
    <mesh_term>Hyaluronic Acid</mesh_term>
    <mesh_term>Retinol palmitate</mesh_term>
    <mesh_term>Fesoterodine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

